Abstract: Local (skeletal muscle and adipose) and systemic inflammation are implicated in the development of obesity-associated insulin resistance in humans. In horses, obesity is neither strongly nor consistently associated with systemic inflammation. The role of skeletal muscle inflammation in the development of insulin dysregulation (insulin resistance or hyperinsulinemia) remains to be determined. We hypothesized that skeletal muscle inflammation is related to obesity-associated hyperinsulinemia in horses. Thirty-five light-breed horses with body condition scores (BCSs) of 3/9 to 9/9 were studied, including 7 obese, normoinsulinemic (BCS ≥ 7, resting serum insulin < 30 μIU/mL) and 6 obese, hyperinsulinemic (resting serum insulin ≥ 30 μIU/mL) horses. Inflammatory biomarkers were evaluated in skeletal muscle biopsies and plasma. Relationships between markers of inflammation and BCS were evaluated. To assess the role of inflammation in obesity-associated hyperinsulinemia, markers of inflammation were compared among lean or ideal, normoinsulinemic (L-NI); obese, normoinsulinemic (O-NI); and obese, hyperinsulinemic (O-HI) horses. Skeletal muscle and plasma tumor necrosis factor alpha (TNFα) concentrations were negatively correlated with BCS. When comparing inflammatory markers among groups, skeletal muscle TNFα was lower in the O-HI group than in the O-NI or L-NI groups. In horses, neither skeletal muscle nor systemic inflammation appears to be positively related to obesity or obesity-associated hyperinsulinemia. L’inflammation locale (muscle squelettique et tissu adipeux) et systémique sont impliquées dans le développement de la résistance à l’insuline associée à l’obésité chez l’humain. Chez les chevaux, l’obésité n’est pas fortement ou de manière constante associée avec l’inflammation systémique. Le rôle de l’inflammation des muscles squelettiques dans le développement de la dérégulation de l’insuline (résistance à l’insuline ou hyper-insulinémie) reste à être déterminé. Nous avons émis l’hypothèse que chez les chevaux l’inflammation des muscles squelettiques est reliée à l’hyper-insulinémie associée à l’obésité. Trente-cinq chevaux de race légère avec des pointages de condition corporelle (PCCs) variant de 3/9 à 9/9 ont été étudiés, incluant sept chevaux obèses, normo-insulinémique (PCC ≥ 7, insuline sérique au repos < 30 μUI/mL) et six chevaux obèses, hyper-insulinémique (insuline sérique au repos ≥ 30 μUI/mL). Les biomarqueurs de l’inflammation ont été évalués dans des biopsies de muscles squelettiques et le plasma. Les relations entre les marqueurs de l’inflammation et le PCC ont été évaluées. Pour apprécier le rôle de l’inflammation dans l’hyper-insulinémie associée à l’obésité, les marqueurs de l’inflammation ont été comparés parmi les chevaux élancés ou idéal, normo-insulinémique (L-NI); les chevaux obèses, normo-insulinémique (O-NI); et les chevaux obèses, hyperinsulinémique (O-HI). Les concentrations du facteur nécrosant des tumeurs alpha (TNFα) étaient corrélées négativement avec le PCC. Lors de la comparaison des marqueurs de l’inflammation entre les groupes, la concentration de TNFα dans les muscles squelettiques était plus basse dans le groupe O-HI que dans les groupes O-NI ou L-NI. Chez les chevaux, ni l’inflammation systémique ou celle des muscles squelettiques ne semblent reliées positivement à l’obésité ou à l’hyper-insulinémie associée à l’obésité.(Traduit par Docteur Serge Messier).
The Equine Research Bank provides access to a large database of publicly available scientific literature. Inclusion in the Research Bank does not imply endorsement of study methods or findings by Mad Barn.
This research summary has been generated with artificial intelligence and may contain errors and omissions. Refer to the original study to confirm details provided. Submit correction.
The research article investigates the relationship between skeletal muscle inflammation and obesity-associated hyperinsulinemia in horses. Findings suggest that neither skeletal muscle nor systemic inflammation appear to be positively correlated with obesity or obesity-associated hyperinsulinemia in horses.
Study Overview and Hypothesis
The study examined thirty-five light-breed horses with body condition scores (BCSs) ranging from 3/9 to 9/9. This sample included seven obese, normoinsulinemic horses (with BCS ≥ 7 and resting serum insulin < 30 μUI/mL) and six obese, hyperinsulinemic horses (with resting serum insulin ≥ 30 μIU/mL).
The study hypothesized that skeletal muscle inflammation is linked to obesity-associated hyperinsulinemia in horses.
Methods and Measurements
Inflammatory biomarkers were evaluated using skeletal muscle biopsies and plasma samples from the horses.
Researchers then assessed the relationships between these inflammation markers and the Body Conditioning Scores of the horses.
The role of inflammation in obesity-associated hyperinsulinemia was studied by comparing inflammation markers among lean or ideal, normoinsulinemic (L-NI); obese, normoinsulinemic (O-NI); and obese, hyperinsulinemic (O-HI) horses.
Findings
Skeletal muscle and plasma concentrations of a substance called tumor necrosis factor alpha (TNFα) were found to be negatively correlated with the BCS. This means that higher BCSs (indicating more fat accumulation) were associated with lower levels of TNFα in the muscle and plasma.
When comparing inflammation markers among the groups, skeletal muscle TNFα was found to be lower in the O-HI group than in the O-NI or L-NI groups. This implies that horses with obesity-associated hyperinsulinemia had lower levels of muscle inflammation as compared to normal or lean horses.
Conclusions
From these findings, it appears that neither skeletal muscle inflammation nor systemic inflammation are positively related to obesity or obesity-associated hyperinsulinemia in horses.
This contradicts the team’s initial hypothesis that suggested a clear connection between skeletal muscle inflammation and obesity-associated hyperinsulinemia.
Cite This Article
APA
Banse HE, Holbrook TC, Frank N, McFarlane D.
(2016).
Relationship of skeletal muscle inflammation with obesity and obesity-associated hyperinsulinemia in horses.
Can J Vet Res, 80(3), 217-224.
Department of Physiological Sciences (Banse, McFarlane) and Department of Veterinary Clinical Sciences (Holbrook), Center for Veterinary Health Sciences, Oklahoma State University, Stillwater, Oklahoma 74078, USA; Department of Clinical Sciences, Cummings School of Veterinary Medicine, Tufts University, North Grafton, Massachusetts 01536, USA (Frank).
Holbrook, Todd C
Department of Physiological Sciences (Banse, McFarlane) and Department of Veterinary Clinical Sciences (Holbrook), Center for Veterinary Health Sciences, Oklahoma State University, Stillwater, Oklahoma 74078, USA; Department of Clinical Sciences, Cummings School of Veterinary Medicine, Tufts University, North Grafton, Massachusetts 01536, USA (Frank).
Frank, Nicholas
Department of Physiological Sciences (Banse, McFarlane) and Department of Veterinary Clinical Sciences (Holbrook), Center for Veterinary Health Sciences, Oklahoma State University, Stillwater, Oklahoma 74078, USA; Department of Clinical Sciences, Cummings School of Veterinary Medicine, Tufts University, North Grafton, Massachusetts 01536, USA (Frank).
McFarlane, Dianne
Department of Physiological Sciences (Banse, McFarlane) and Department of Veterinary Clinical Sciences (Holbrook), Center for Veterinary Health Sciences, Oklahoma State University, Stillwater, Oklahoma 74078, USA; Department of Clinical Sciences, Cummings School of Veterinary Medicine, Tufts University, North Grafton, Massachusetts 01536, USA (Frank).
MeSH Terms
Animals
Biomarkers
Female
Gene Expression Regulation
Horse Diseases / etiology
Horses
Hyperinsulinism / complications
Hyperinsulinism / veterinary
Inflammation / complications
Inflammation / veterinary
Insulin / metabolism
Male
Muscle, Skeletal / pathology
Muscular Diseases / complications
Muscular Diseases / veterinary
Obesity / complications
Obesity / veterinary
References
This article includes 43 references
Tantiwong P, Shanmugasundaram K, Monroy A, Ghosh S, Li M, DeFronzo RA, Cersosimo E, Sriwijitkamol A, Mohan S, Musi N. NF-κB activity in muscle from obese and type 2 diabetic subjects under basal and exercise-stimulated conditions.. Am J Physiol Endocrinol Metab 2010 Nov;299(5):E794-801.
Plomgaard P, Nielsen AR, Fischer CP, Mortensen OH, Broholm C, Penkowa M, Krogh-Madsen R, Erikstrup C, Lindegaard B, Petersen AM, Taudorf S, Pedersen BK. Associations between insulin resistance and TNF-alpha in plasma, skeletal muscle and adipose tissue in humans with and without type 2 diabetes.. Diabetologia 2007 Dec;50(12):2562-71.
Bastard JP, Maachi M, Lagathu C, Kim MJ, Caron M, Vidal H, Capeau J, Feve B. Recent advances in the relationship between obesity, inflammation, and insulin resistance.. Eur Cytokine Netw 2006 Mar;17(1):4-12.
Yang RZ, Lee MJ, Hu H, Pollin TI, Ryan AS, Nicklas BJ, Snitker S, Horenstein RB, Hull K, Goldberg NH, Goldberg AP, Shuldiner AR, Fried SK, Gong DW. Acute-phase serum amyloid A: an inflammatory adipokine and potential link between obesity and its metabolic complications.. PLoS Med 2006 Jun;3(6):e287.
Park HS, Park JY, Yu R. Relationship of obesity and visceral adiposity with serum concentrations of CRP, TNF-alpha and IL-6.. Diabetes Res Clin Pract 2005 Jul;69(1):29-35.
Calabro P, Chang DW, Willerson JT, Yeh ET. Release of C-reactive protein in response to inflammatory cytokines by human adipocytes: linking obesity to vascular inflammation.. J Am Coll Cardiol 2005 Sep 20;46(6):1112-3.
Anty R, Bekri S, Luciani N, Saint-Paul MC, Dahman M, Iannelli A, Amor IB, Staccini-Myx A, Huet PM, Gugenheim J, Sadoul JL, Le Marchand-Brustel Y, Tran A, Gual P. The inflammatory C-reactive protein is increased in both liver and adipose tissue in severely obese patients independently from metabolic syndrome, Type 2 diabetes, and NASH.. Am J Gastroenterol 2006 Aug;101(8):1824-33.
Yudkin JS, Kumari M, Humphries SE, Mohamed-Ali V. Inflammation, obesity, stress and coronary heart disease: is interleukin-6 the link?. Atherosclerosis 2000 Feb;148(2):209-14.
Trayhurn P, Drevon CA, Eckel J. Secreted proteins from adipose tissue and skeletal muscle - adipokines, myokines and adipose/muscle cross-talk.. Arch Physiol Biochem 2011 May;117(2):47-56.
Daoussis D, Antonopoulos I, Yiannopoulos G, Andonopoulos AP. ACTH as first line treatment for acute calcium pyrophosphate crystal arthritis in 14 hospitalized patients.. Joint Bone Spine 2014 Jan;81(1):98-100.
Levine T. Treating refractory dermatomyositis or polymyositis with adrenocorticotropic hormone gel: a retrospective case series.. Drug Des Devel Ther 2012;6:133-9.
Getting SJ, Christian HC, Flower RJ, Perretti M. Activation of melanocortin type 3 receptor as a molecular mechanism for adrenocorticotropic hormone efficacy in gouty arthritis.. Arthritis Rheum 2002 Oct;46(10):2765-75.
Andreasson A, Kiss NB, Juhlin CC, Höög A. Long-term storage of endocrine tissues at - 80°C does not adversely affect RNA quality or overall histomorphology.. Biopreserv Biobank 2013 Dec;11(6):366-70.
Saghizadeh M, Ong JM, Garvey WT, Henry RR, Kern PA. The expression of TNF alpha by human muscle. Relationship to insulin resistance.. J Clin Invest 1996 Feb 15;97(4):1111-6.
Spranger J, Kroke A, Möhlig M, Hoffmann K, Bergmann MM, Ristow M, Boeing H, Pfeiffer AF. Inflammatory cytokines and the risk to develop type 2 diabetes: results of the prospective population-based European Prospective Investigation into Cancer and Nutrition (EPIC)-Potsdam Study.. Diabetes 2003 Mar;52(3):812-7.
Phillips CM, Perry IJ. Does inflammation determine metabolic health status in obese and nonobese adults?. J Clin Endocrinol Metab 2013 Oct;98(10):E1610-9.
Plomgaard P, Nielsen AR, Fischer CP, Mortensen OH, Broholm C, Penkowa M, Krogh-Madsen R, Erikstrup C, Lindegaard B, Petersen AM, Taudorf S, Pedersen BK. Associations between insulin resistance and TNF-alpha in plasma, skeletal muscle and adipose tissue in humans with and without type 2 diabetes.. Diabetologia 2007 Dec;50(12):2562-71.
de Alvaro C, Teruel T, Hernandez R, Lorenzo M. Tumor necrosis factor alpha produces insulin resistance in skeletal muscle by activation of inhibitor kappaB kinase in a p38 MAPK-dependent manner.. J Biol Chem 2004 Apr 23;279(17):17070-8.
Plomgaard P, Penkowa M, Pedersen BK. Fiber type specific expression of TNF-alpha, IL-6 and IL-18 in human skeletal muscles.. Exerc Immunol Rev 2005;11:53-63.